Guido Fiorentini, M.D., Ph.D.

Education

• Universita degli Studi di Ferrara
• Doctor of Philosophy, University of Pavia

Residency

• General Surgery, University Vita Salute San Raffaele
• General Surgery, Mayo Clinic School of Graduate Medical Education

Fellowship

• Hepatobiliary and Pancreas Surgery, Mayo Clinic School of Graduate Medical Education

Membership

• Fellow Representative, Americas Hepatobiliary Association

• Ampullary cancer
• Bile ducts: cyst, injury, stone and stricture
• Carcinoid tumor
• Cholangiocarcinoma
• Duodenal cancer
• Gallbladder: cancer and polyps
• Gastrointestinal stromal tumor
• Hepatocellular carcinoma
• Immune thrombocytopenia
• Intraductal papillary mucinous neoplasm
• Liver: abscess, cancer, cyst, hemangioma and mass
• Neuroendocrine: liver metastasis and tumors
• Pancreatic: cancer, cyst, neuroendocrine tumor
• Pancreatitis
• Recurrent cancer
• Small bowel cancer
• Stage 4 colorectal cancer

• Outcomes of palliative porto-mesenteric venous stenting in unresectable pancreatic malignancies, September 2025.
• Safety of laparoscopic compared to open right hepatectomy after portal vein occlusion: results from a multicenter study, March 2025.
• Failed recovery after pancreatoduodenectomy: A significant problem even without surgical complications, October 2024.
• The differential benefit of laparoscopic over open minor liver resection for lesions situated in the anterolateral or posterosuperior segments, August 2024.
• Minimally invasive vs. open approach to the simultaneous treatment of colorectal tumors with synchronous liver metastasis: a single center, propensity-score matched analysis from Mayo clinic, November 2023.